CDER Adds Gaucher Disease to 2017 Guidance Agenda Post author:Sam Post published:April 20, 2017 Post category:Drug Industry Daily CDER updated its guidance agenda for 2017, adding an item on Gaucher Disease. Source: Drug Industry Daily You Might Also Like FDA Warns California OTC Drugmaker for Defective Products March 29, 2019 Califf Outlines FDA’s Newest Efforts to Address Opioid Crisis April 20, 2022 FDA’s Expedited Review Pathways to Speed Drug Approvals April 13, 2023
